Chuck Triano

Bio:

Chuck Triano has over 27 years of experience in corporate investor relations in the BIoPharma sector.  Prior to that he spent over a decade providing capital markets intelligence to corporate issuers.  He currently serves as Senior Vice President of Investor Relations at Bristol Myers Squibb, a position held since October 2024. Prior to this role, Chuck was Head of Investor Relations at Biogen from April 2023 to October 2024 and served as both Advisor and Chief Financial Officer at Xalud Therapeutics, Inc. from November 2021 to October 2024. Chuck's extensive experience in investor relations includes a significant tenure at Pfizer as Senior Vice President of Investor Relations from June 2008 to November 2021 and as Vice President of Investor Relations at Forest Laboratories from June 2000 to June 2008. Chuck began the career in investor relations at Bristol-Myers Squibb, serving as Director of Investor Relations from June 1998 to June 2000. Chuck holds a BA in Economics  from the University of Connecticut.